Literature DB >> 17102561

How reliable are models for malaria vaccine development? Lessons from irradiated sporozoite immunizations.

S Chatterjee1, J L Perignon, E Van Marck, P Druilhe.   

Abstract

Models occupy a key position in the development of anti-parasitic vaccines, yet their relevance has been seldom addressed. It is customary to admit that malaria vaccine development requires easy-to-handle, laboratory models. Animal models involving predominantly inbred rodents and primates as parasite hosts are currently the basic tools for the study of host-parasite interactions. Literature however indicates that the induction of host protection is more difficult in natural host-parasite pairs than in experimental models of parasite infection. Moreover different models delineate a wide range of host-pathogen relationship profiles providing a mosaic of contradictory informations, yet there is little incentive to delineate their relevance or to exploit recent advances to develop improved model systems. In this context the analysis of natural host-parasite interactions between Plasmodium berghei and its mammalian host and reservoir, the tree rat Grammomys surdaster could ge of relevance in the study of host-parasite interactions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17102561

Source DB:  PubMed          Journal:  J Postgrad Med        ISSN: 0022-3859            Impact factor:   1.476


  3 in total

1.  Grammomys surdaster, the Natural Host for Plasmodium berghei Parasites, as a Model to Study Whole-Organism Vaccines Against Malaria.

Authors:  Solomon Conteh; Charles Anderson; Lynn Lambert; Sachy Orr-Gonzalez; Jessica Herrod; Yvette L Robbins; Dariyen Carter; Stomy Bin Shamamba Karhemere; Pati Pyana; Philippe Büscher; Patrick E Duffy
Journal:  Am J Trop Med Hyg       Date:  2017-01-23       Impact factor: 2.345

2.  Interferon-γ, a valuable surrogate marker of Plasmodium falciparum pre-erythrocytic stages protective immunity.

Authors:  Blanca-Liliana Perlaza; Jean-Pierre Sauzet; Karima Brahimi; Lbachir BenMohamed; Pierre Druilhe
Journal:  Malar J       Date:  2011-02-08       Impact factor: 2.979

3.  Potent antibody lineage against malaria transmission elicited by human vaccination with Pfs25.

Authors:  Brandon McLeod; Kazutoyo Miura; Stephen W Scally; Alexandre Bosch; Ngan Nguyen; Hanjun Shin; Dongkyoon Kim; Wayne Volkmuth; Sebastian Rämisch; Jessica A Chichester; Stephen Streatfield; Colleen Woods; William R Schief; Daniel Emerling; C Richter King; Jean-Philippe Julien
Journal:  Nat Commun       Date:  2019-09-24       Impact factor: 14.919

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.